MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma

被引：12
|
作者：
Olarte, Irma [1 ]
Martinez, Adolfo [1 ]
Ramos-Penafiel, Christian [1 ]
Castellanos-Sinco, Humberto [1 ]
Zamora, Jorge [1 ]
Collazo-Jaloma, Juan [1 ]
Gutierrez, Mario [1 ]
Gutierrez-Kobeh, Laila [2 ]
Chavez-Olmos, Pedro [3 ]
Manzanilla, Hugo [4 ]
Garrido-Guerrero, Efrain [3 ]
Ordonez-Razo, Rosa M. [5 ]
Miranda, Enrique I. [1 ,6 ]
机构：
[1] Hosp Gen Mexico City, Serv Hematol, Lab Biol Mol, Mexico City 06726, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Sch Med, Mexico City, DF, Mexico
[3] CINVESTAV IPN, Dept Genet & Biol Mol, Mexico City, DF, Mexico
[4] Hosp Gen Mexico City, Serv Urol, Mexico City 06726, DF, Mexico
[5] IMSS, Ctr Med Siglo 21, Hosp Pediat, Unidad Invest Med Genet Humana, Mexico City, DF, Mexico
[6] Westhill Univ, Sch Med, Mexico City, DF, Mexico
来源：
HEMATOLOGY | 2011年 / 16卷 / 06期
关键词：
MAGE-A3; Expression; Prognostic; DLBCL; Lymphoma; NON-HODGKINS-LYMPHOMA; TISSUE MICROARRAY; GENE-EXPRESSION; CANCER; CHEMOTHERAPY; PREDICTION; CARCINOMA; SURVIVAL; MYELOMA; ANTIGEN;
D O I：
10.1179/102453311X13085644680384
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This study evaluates the prognostic value of MAGE-A3 expression in 28 diffuse large B-cell lymphoma (DLBCL) patients. A significant association was observed between MAGE-A3 expressions, assessed by quantitative real-time RT-polymerase chain reaction (PCR), with advanced stages of disease (P<0.05). Elevated serum lactate dehydrogenase (LDH) levels and International Prognostic Index (IPI) score were significantly higher in MAGE-A3-positive patients (P=0.025 and P=0.004, respectively). Expression of MAGE-A3 was associated with poor response to treatment and a significantly shorter overall survival (P<0.001). Our data address new information in the association of MAGE-A3 expression and poor prognosis in DLBCL patients.
引用
收藏
页码：368 / 372
页数：5
相关论文
共 50 条
  • [21] Serum hepatitis B core antibody as the prognostic factor for diffuse large B-cell lymphoma
    Rong, Yi
    Wang, Ming
    Ma, Yaqiong
    Liang, Yuanchen
    Ye, Lvyin
    Guo, Lin
    Lu, Renquan
    Wang, Yanchun
    MICROBIOLOGY SPECTRUM, 2025,
  • [22] Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
    Park, Jeayeon
    Chung, Sung Won
    Lee, Yun Bin
    Shin, Hyunjae
    Hur, Moon Haeng
    Cho, Heejin
    Park, Min Kyung
    Youk, Jeonghwan
    Lee, Ji Yun
    Lee, Jeong-Ok
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Kim, Tae Min
    Lee, Jeong-Hoon
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (03) : 794 - 809
  • [23] Adverse prognostic impact of vascular endothelial growth factor gene polymorphisms in patients with diffuse large B-cell lymphoma
    Yoon, Kyong-Ah
    Kim, Min Kyeong
    Eom, Hyeon-Seok
    Lee, Hyewon
    Park, Weon Seo
    Sohn, Ji Yeon
    Kim, Man Jin
    Kong, Sun-Young
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2677 - 2682
  • [24] Dual Translocation Is An Independent Poor Prognostic Factor in Diffuse Large B-Cell Lymphoma
    Tay, Kevin
    Lai, Gillianne
    Chua, Elaine J.
    Ong, Whee Sze
    Tang, Tiffany
    Quek, Richard
    Tan, Daryl
    Tan, Leonard
    Tao, Miriam
    Tan, Soo Yong
    Lim, Soon Thye
    BLOOD, 2011, 118 (21) : 1574 - 1574
  • [25] Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
    Fuertes, Silvia
    Setoain, Xavier
    Lopez-Guillermo, Armando
    Carrasco, Josep-Lluis
    Rodriguez, Sonia
    Rovira, Jordina
    Pons, Francesca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) : 496 - 504
  • [26] Diffuse large B-cell lymphoma - Molecular heterogeneity of diffuse large B-cell lymphoma
    Gascoyne, RD
    HEMATOLOGY JOURNAL, 2004, 5 : S144 - S148
  • [27] Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
    Silvia Fuertes
    Xavier Setoain
    Armando Lopez-Guillermo
    Josep-Lluis Carrasco
    Sonia Rodríguez
    Jordina Rovira
    Francesca Pons
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 496 - 504
  • [28] Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
    Nobuhiko Nakamura
    Takeshi Hara
    Yuhei Shibata
    Takuro Matsumoto
    Hiroshi Nakamura
    Soranobu Ninomiya
    Yusuke Kito
    Junichi Kitagawa
    Nobuhiro Kanemura
    Naoe Goto
    Makoto Shiraki
    Tatsuhiko Miyazaki
    Tamotsu Takeuchi
    Masahito Shimizu
    Hisashi Tsurumi
    Annals of Hematology, 2015, 94 : 2043 - 2053
  • [29] Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
    Nakamura, Nobuhiko
    Hara, Takeshi
    Shibata, Yuhei
    Matsumoto, Takuro
    Nakamura, Hiroshi
    Ninomiya, Soranobu
    Kito, Yusuke
    Kitagawa, Junichi
    Kanemura, Nobuhiro
    Goto, Naoe
    Shiraki, Makoto
    Miyazaki, Tatsuhiko
    Takeuchi, Tamotsu
    Shimizu, Masahito
    Tsurumi, Hisashi
    ANNALS OF HEMATOLOGY, 2015, 94 (12) : 2043 - 2053
  • [30] Molecular prognostic factors in diffuse large B-cell lymphoma
    Morgensztern D.
    Lossos I.S.
    Current Treatment Options in Oncology, 2005, 6 (4) : 269 - 277
12345